ARCHER MATERIALS Aktie

 

Archer Materials pivots to real-world markets, with Biochip-driven, quantitative, point-of-care potassium testing—potentially cutting hyperkalemia costs....

Archer Materials is moving from R&D to commercialisation, with silicon biochips via IMEC, on-chip quantum sensing, and CSIRO QML fraud-detection for 2026 beta....

Archer Materials (ASX: AXE) charts a scalable, semiconductor-ready path to commercial quantum tech with the 12CQ project, targeting a 2026 qubit....

Archer Materials (ASX: AXE) has achieved a significant milestone with its Biochip technology, unveiling an alpha prototype of a potassium sensor that meets clinical-grade accuracy standards....

Archer Materials advances carbon qubit 12CQ readout; silicon biochip hits potassium accuracy with IMEC; collabs with Emergence Quantum and CSIRO....

For many investors, the word "silicon" calls to mind the computer revolution of the 80s and 90s, but for Archer Materials (ASX: AXE), it represents a potential lifeline for kidney disease patients and a pathway to scalable manufacturing for a medical device....

Archer Materials (ASX: AXE) has achieved a key milestone on the journey to qubit demonstration by showing it can electrically-control its quantum device to enable an accurate read-out of quantum information....

Archer Materials (ASX: AXE) has signed a research services agreement with the CSIRO's data and digital specialist arm to advance quantum machine learning for fraud detection in financial transactions....

Initial data from first-stage testing of Archer Materials' (ASX: AXE) blood potassium graphene Biochip project have shown the technology suitable for silicon for point-of-care and at-home diagnostic applications. Archer expects the findings to de-risk its supply chain, reduce unit costs, and accelerate the pathway towards manufacture and commercialisation. The company is now on track to […] The post Archer Materials Confirms Suitability of Silicon Foundation for Potassium-Sensing Biochip Device appeared first on Small Caps....

Semiconductor company Archer Materials (ASX: AXE) has completed the demonstration of highly-sensitive magnetic field measurements at cryogenic temperatures using its tunnel magnetoresistance (TMR) sensor technology. The work is part of the company's 12CQ quantum project focused on developing a carbon-based quantum bit (qubit) semiconductor chip with high bandwidth and low power consumption to replace traditional […] The post Archer Materials Advances Quantum Tech with Cryogenic TMR Sensor Demonstration appeared first on Small Caps....

Archer Materials (ASX: AXE) has signed a $450,000 deal with UK-based graphene electronics company Paragraf to develop its Biochip potassium-sensing device for in-home testing of chronic kidney disease. The six-month project will accelerate technical progress towards meeting the blood potassium sensing target product profile using a graphene field-effect transistor (gFET). Both companies will leverage their […] The post Archer Materials partners with Paragraf to accelerate development of potassium-sensing Biochip device appeared first on Small Caps....

Archer Materials (ASX: AXE) has signed an agreement with Canadian medical device company Hylid Diagnostics to develop a potassium measurement product for at-home testing of chronic kidney disease. The partnership will combine Archer's Biochip potassium-sensing technology with Hylid's blood haemolysis sensor technology to develop a prototype at-home testing device that meets stringent accuracy requirements for […] The post Archer Materials and Hylid Diagnostics partner to develop at-home potassium test for kidney disease appeared first on Small Caps....